Central Trust Company’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.06M | Sell |
6,929
-61
| -0.9% | -$9.35K | 0.02% | 338 |
|
|
2025
Q4 | $964K | Sell |
6,990
-260
| -4% | -$34K | 0.02% | 347 |
|
|
2025
Q3 | $930K | Sell |
7,250
-79
| -1% | -$9.64K | 0.02% | 345 |
|
|
2025
Q2 | $887K | Hold |
7,329
| – | – | 0.02% | 340 |
|
|
2025
Q1 | $817K | Buy |
7,329
+256
| +4% | +$27.3K | 0.02% | 344 |
|
|
2024
Q4 | $688K | Buy |
7,073
+5
| +0.1% | +$533 | 0.02% | 367 |
|
|
2024
Q3 | $813K | Sell |
7,068
-318
| -4% | -$36.1K | 0.02% | 351 |
|
|
2024
Q2 | $786K | Sell |
7,386
-249
| -3% | -$25K | 0.02% | 347 |
|
|
2024
Q1 | $739K | Sell |
7,635
-510
| -6% | -$52.3K | 0.02% | 364 |
|
|
2023
Q4 | $822K | Buy |
8,145
+70
| +0.9% | +$6.76K | 0.02% | 338 |
|
|
2023
Q3 | $823K | Sell |
8,075
-7
| -0.1% | -$711 | 0.02% | 338 |
|
|
2023
Q2 | $816K | Buy |
8,082
+355
| +5% | +$35.5K | 0.02% | 348 |
|
|
2023
Q1 | $711K | Buy |
7,727
+270
| +4% | +$23.6K | 0.02% | 352 |
|
|
2022
Q4 | $676K | Buy |
7,457
+76
| +1% | +$6.4K | 0.02% | 348 |
|
|
2022
Q3 | $561K | Sell |
7,381
-644
| -8% | -$53.4K | 0.02% | 357 |
|
|
2022
Q2 | $678K | Sell |
8,025
-500
| -6% | -$43.9K | 0.02% | 338 |
|
|
2022
Q1 | $748K | Buy |
8,525
+136
| +2% | +$11.8K | 0.02% | 350 |
|
|
2021
Q4 | $734K | Sell |
8,389
-94
| -1% | -$7.8K | 0.02% | 377 |
|
|
2021
Q3 | $694K | Sell |
8,483
-200
| -2% | -$18K | 0.02% | 374 |
|
|
2021
Q2 | $792K | Buy |
8,683
+200
| +2% | +$17.8K | 0.03% | 344 |
|
|
2021
Q1 | $725K | Sell |
8,483
-1,874
| -18% | -$168K | 0.03% | 345 |
|
|
2020
Q4 | $978K | Sell |
10,357
-461
| -4% | -$40.3K | 0.04% | 281 |
|
|
2020
Q3 | $941K | Sell |
10,818
-1,904
| -15% | -$165K | 0.04% | 257 |
|
|
2020
Q2 | $1.11M | Sell |
12,722
-486
| -4% | -$42K | 0.06% | 225 |
|
|
2020
Q1 | $1.09M | Buy |
13,208
+623
| +5% | +$55.6K | 0.07% | 211 |
|
|
2019
Q4 | $1.19M | Buy |
12,585
+1,997
| +19% | +$179K | 0.06% | 233 |
|
|
2019
Q3 | $920K | Buy |
10,588
+728
| +7% | +$65.4K | 0.05% | 256 |
|
|
2019
Q2 | $890K | Sell |
9,860
-831
| -8% | -$70.3K | 0.05% | 254 |
|
|
2019
Q1 | $921K | Buy |
10,691
+22
| +0.2% | +$1.77K | 0.05% | 241 |
|
|
2018
Q4 | $821K | Sell |
10,669
-301
| -3% | -$23.4K | 0.05% | 241 |
|
|
2018
Q3 | $847K | Sell |
10,970
-103
| -0.9% | -$7.61K | 0.05% | 259 |
|
|
2018
Q2 | $750K | Sell |
11,073
-3,596
| -25% | -$248K | 0.05% | 273 |
|
|
2018
Q1 | $1.06M | Buy |
14,669
+3,587
| +32% | +$273K | 0.07% | 235 |
|
|
2017
Q4 | $833K | Sell |
11,082
-951
| -8% | -$71.8K | 0.05% | 266 |
|
|
2017
Q3 | $926K | Buy |
12,033
+115
| +1% | +$8.69K | 0.06% | 247 |
|
|
2017
Q2 | $891K | Sell |
11,918
-2,514
| -17% | -$178K | 0.06% | 254 |
|
|
2017
Q1 | $961K | Sell |
14,432
-126
| -0.9% | -$8.4K | 0.06% | 233 |
|
|
2016
Q4 | $950K | Buy |
14,558
+210
| +1% | +$13.6K | 0.07% | 233 |
|
|
2016
Q3 | $1.02M | Buy |
14,348
+42
| +0.3% | +$3.06K | 0.07% | 214 |
|
|
2016
Q2 | $1.06M | Buy |
14,306
+504
| +4% | +$34.8K | 0.08% | 215 |
|
|
2016
Q1 | $896K | Buy |
13,802
+2,956
| +27% | +$201K | 0.07% | 223 |
|
|
2015
Q4 | $836K | Buy |
10,846
+179
| +2% | +$14.2K | 0.07% | 226 |
|
|
2015
Q3 | $879K | Sell |
10,667
-4
| -0% | -$356 | 0.08% | 218 |
|
|
2015
Q2 | $941K | Sell |
10,671
-47
| -0.4% | -$4.31K | 0.07% | 226 |
|
|
2015
Q1 | $947K | Sell |
10,718
-384
| -3% | -$34.1K | 0.08% | 209 |
|
|
2014
Q4 | $921K | Buy |
11,102
+77
| +0.7% | +$6.38K | 0.08% | 209 |
|
|
2014
Q3 | $930K | Sell |
11,025
-704
| -6% | -$57K | 0.07% | 221 |
|
|
2014
Q2 | $952K | Sell |
11,729
-7
| -0.1% | -$551 | 0.08% | 216 |
|
|
2014
Q1 | $894K | Sell |
11,736
-802
| -6% | -$58.4K | 0.07% | 220 |
|
|
2013
Q4 | $903K | Sell |
12,538
-373
| -3% | -$25.9K | 0.08% | 218 |
|
|
2013
Q3 | $888K | Sell |
12,911
-307
| -2% | -$20.3K | 0.08% | 207 |
|
|
2013
Q2 | $837K | Buy |
+13,218
| New | +$860K | 0.08% | 210 |
|
Other funds holding NVS
Central Trust Company's NVS Position: Q1 2026 in Review
Central Trust Company reduced its Novartis (NVS) stake by 0.87% in Q1 2026, selling an estimated $9.35K and leaving 6,929 shares worth $1.06M. The position accounts for 0.02% of the portfolio, ranked #338.
Central Trust Company first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.19M in Q4 2019. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Central Trust Company held 6,929 shares of Novartis worth $1.06M as of Q1 2026.
- Central Trust Company sold 61 Novartis shares in Q1 2026, an estimated $9.35K.
- Novartis made up 0.02% of Central Trust Company's portfolio in Q1 2026, its #338 holding.
- Central Trust Company first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- Central Trust Company's Novartis position peaked at $1.19M in Q4 2019.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.